Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New COVID-19 vaccine shows promise in early human trials

NCT ID NCT04537208

First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 29 times

Summary

This study tested a new COVID-19 vaccine in 441 healthy adults aged 18 and older. The goal was to see how well the vaccine triggered an immune response and whether it was safe. Participants received different versions of the vaccine, with or without an adjuvant, and were followed for up to a year.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 (HEALTHY VOLUNTEERS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Investigational Site Number 8400001

    Rochester, New York, 14609, United States

  • Investigational Site Number 8400002

    Omaha, Nebraska, 68134, United States

  • Investigational Site Number 8400003

    Philadelphia, Pennsylvania, 19104, United States

  • Investigational Site Number 8400004

    Birmingham, Alabama, 35294, United States

  • Investigational Site Number 8400007

    Rochester, New York, 14642, United States

  • Investigational Site Number 8400008

    Cleveland, Ohio, 44122, United States

  • Investigational Site Number 8400011

    Hollywood, Florida, 33024, United States

  • Investigational Site Number 8400012

    Rolling Hills Estates, California, 90274, United States

  • Investigational Site Number 8400014

    Mt. Pleasant, South Carolina, 29464, United States

  • Investigational Site Number 8400016

    Boston, Massachusetts, 02115, United States

  • Investigational Site Number 8400019

    Melbourne, Florida, 32934, United States

Conditions

Explore the condition pages connected to this study.